Augmedix Inc
NASDAQ:AUGX
Augmedix Inc
NASDAQ:AUGX
Price:
2.89 USD
1.4%
Market Closed
Updated:
Apr 29, 2024
P/E
Price to Earnings
Price to Earnings
-7.3
Current
-6.6
Median
23.2
Industry
Lower
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-7.3
Market Cap
/
140.5m
Net Income
-19.2m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Augmedix Inc
NASDAQ:AUGX
|
140.5m USD | -7.3 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.6B USD | 61.9 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 47.3 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | -116.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY | 27.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.7B AUD | 167.3 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.1B USD | -337.1 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 32.9 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.9B SEK | 101 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.2B USD | -22.5 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | -319.3 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
-5.5
2-Years Forward
P/E
-7.5
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
